Related Experiment Videos
[Study of survival using anistreplase (Eminase)]
1Department of Cardiology, East Birmingham District General Hospital, United-Kingdom.
Archives Des Maladies Du Coeur Et Des Vaisseaux
|February 1, 1990
Summary
This review examines survival data for Eminase, a thrombolytic agent for acute myocardial infarction. It assesses Eminase
Area of Science:
- Cardiovascular Medicine
- Pharmacology
Background:
- Thrombolytic therapy is a critical advancement in treating cardiovascular diseases.
- Ongoing research focuses on developing novel thrombolytic agents with rapid action.
- Evaluating thrombolytic efficacy involves assessing reperfusion, recanalization, cardiac function, and survival rates.
Purpose of the Study:
- To review survival study results for Eminase.
- To evaluate Eminase as a thrombolytic agent for acute myocardial infarction.
Main Methods:
- Review of published survival studies.
- Analysis of data pertaining to acute myocardial infarction treatment.
Main Results:
- Survival is the primary endpoint for assessing thrombolytic protocols.
- Eminase is identified as a new thrombolytic agent.
Conclusions:
- Survival data is crucial for validating thrombolytic therapies.
- Eminase warrants further investigation in the context of acute myocardial infarction treatment.